Chi2Gel

Chi2Gel is a French biotechnology company specializing in the development of innovative chitosan-based hydrogels for medical and pharmaceutical applications. The company's proprietary technology focuses on a physical hydrogel formed through the self-assembly of chitosan chains, offering a biocompatible and biodegradable scaffold for tissue engineering and controlled drug release. Chi2Gel's platform is designed to address unmet needs in regenerative medicine, particularly in areas such as cartilage repair and chronic wound management. By leveraging the natural properties of chitosan without the need for toxic cross-linking agents, the company provides a safe and versatile solution for various therapeutic delivery challenges.